Latest filing published 15 May 2026 for Forian Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Kristiina Vuori MD span 3 companies, the busiest being Inhibrx Biosciences, Inc., WebMD Health Corp. and Forian Inc. The record holds 10 filings, for trades running from 15 November 2016 to 15 May 2026.
On the open market, the record shows 4 purchases worth €272k and 2 sales worth €78k. Taken together, the purchases exceed the sales by €193k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants.
In size, the median ticket on the buying side is €89k. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The record was last updated on 15 May 2026 with a transaction in Forian Inc. The latest purchase dates back some time: it was published 747 days ago, on 7 October 2024. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations